Wiley Bros. Aintree Capital, LLC Quest Diagnostics Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,563 shares of DGX stock, worth $625,541. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,563Holding current value
$625,541% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding DGX
# of Institutions
909Shares Held
96.1MCall Options Held
587KPut Options Held
235K-
Vanguard Group Inc Valley Forge, PA14MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.19MShares$712 Million0.03% of portfolio
-
Victory Capital Management Inc3.88MShares$532 Million0.55% of portfolio
-
American Century Companies Inc Kansas City, MO2.85MShares$391 Million0.24% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...